Influencing and shaping our sector | BIA update January - April 2019

Announcement of a placement, working with an international biotech backed by UK and global VCs.

New Moderna Innovation and Technology Centre opened as government further boosts life sciences sector with £50 million fund.

This strategic hire marks a significant step in the firm’s expansion within the Swiss market and the broader DACH region.

As custodians of the triple award-winning Advanced Therapies Apprenticeship Community (ATAC), Cell and Gene Therapy Catapult are excited to announce that we are sponsoring the first ever Apprentice of the Year award at the ever-popular annual bioProcessUK Conference, taking place in Newcastle on 25-27 November 2025.

Myricx Bio (‘Myricx’), a private biotech company focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates (ADCs), is scaling ahead of entering the clinic and is pleased to announce the appointment of Boston-based Mohit Rawat as its Chief Executive Officer (CEO) and member of the Board of Directors.

This is my final CEO update in Newscast after 13 years at the BIA. I take up my new role as Executive Chair of the Office for Life Sciences next Monday. Before I do, I want to thank you - my loyal readers - for engaging with my musings over the years, and for your feedback that has improved this blog and my thinking.